211 related articles for article (PubMed ID: 34674457)
1. [Interpretation of updated international guidelines for diagnosis and treatment of gastroenter-opancreatic neuroendocrine neoplasms].
Chen LH; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):843-848. PubMed ID: 34674457
[TBL] [Abstract][Full Text] [Related]
2. [Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].
Grabowski P; Hörsch D
Z Gastroenterol; 2015 Oct; 53(10):1194-200. PubMed ID: 26480056
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
4. [Interpretation of the latest guidelines in the treatment of gastrointestinal neuroendocrine neoplasms].
Chen L; Chen J; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1201-1204. PubMed ID: 27928785
[TBL] [Abstract][Full Text] [Related]
5. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
7. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
Chen H; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Oberg K; Akerström G; Rindi G; Jelic S;
Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
[No Abstract] [Full Text] [Related]
9. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
Gonzalez RS
Surg Pathol Clin; 2020 Sep; 13(3):377-397. PubMed ID: 32773190
[TBL] [Abstract][Full Text] [Related]
10. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).
Plöckinger U; Rindi G; Arnold R; Eriksson B; Krenning EP; de Herder WW; Goede A; Caplin M; Oberg K; Reubi JC; Nilsson O; Delle Fave G; Ruszniewski P; Ahlman H; Wiedenmann B;
Neuroendocrinology; 2004; 80(6):394-424. PubMed ID: 15838182
[No Abstract] [Full Text] [Related]
12. Neuroendocrine neoplasms of the gastrointestinal tract.
Schott M; Klöppel G; Raffel A; Saleh A; Knoefel WT; Scherbaum WA
Dtsch Arztebl Int; 2011 May; 108(18):305-12. PubMed ID: 21629514
[TBL] [Abstract][Full Text] [Related]
13. An Update on Gastroenteropancreatic Neuroendocrine Neoplasms: From Mysteries to Paradigm Shifts.
Ramírez-Rentería C; Ferreira-Hermosillo A; Marrero-Rodríguez D; Taniguchi-Ponciano K; Melgar-Manzanilla V; Mercado M
Arch Med Res; 2020 Nov; 51(8):765-776. PubMed ID: 32654882
[TBL] [Abstract][Full Text] [Related]
14. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A
World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070
[TBL] [Abstract][Full Text] [Related]
15. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
Niederle MB; Hackl M; Kaserer K; Niederle B
Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
[TBL] [Abstract][Full Text] [Related]
16. Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS).
Chan DL; Moody L; Segelov E; Metz DC; Strosberg JR; Pavlakis N; Singh S
Neuroendocrinology; 2018; 107(1):32-41. PubMed ID: 29539613
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():150-3. PubMed ID: 19454440
[No Abstract] [Full Text] [Related]
18. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
19. [Neuroendocrine neoplasms of the gastrointestinal tract. Classification, clinical presentation and diagnosis].
Fottner C; Weber MM
Internist (Berl); 2012 Feb; 53(2):131-44. PubMed ID: 22290317
[TBL] [Abstract][Full Text] [Related]
20. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
